Bridging the Early Diagnosis and Treatment Gaps of Brain Diseases
ALAMEDA is a European collaborative R&I project that receives funding from the European Research and Innovation Programme Horizon 2020 and kicked off last 25th of January 2021.
ALAMEDA acknowledges that the care of patients with brain disorders is complex and manifestations of certain diseases could worsen over time and seriously impair the quality of life of patients and their caregivers.
Through the use of Artificial Intelligence (AI) healthcare support systems, the project aims to provide personalised rehabilitation treatment assessments for patients with Parkinson’s, Multiple Sclerosis and Stroke, to ensure that medical interventions are effective and that situations likely to aggravate can be predicted.
word ALAMEDA means tree-lined avenue.
The ALAMEDA consortium is a multidisciplinary, cohesive and enthusiastic team of experts who are willing to walk together the ALAMEDA path towards the accomplishment of our mission: delivering better care and quality of life for people with brain disorders.